Age-related changes in hepatic activity and expression of detoxification enzymes in male rats
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
23971034
PubMed Central
PMC3736498
DOI
10.1155/2013/408573
Knihovny.cz E-zdroje
- MeSH
- aktivace enzymů MeSH
- antioxidancia metabolismus MeSH
- játra enzymologie MeSH
- krysa rodu Rattus MeSH
- léčivé přípravky MeSH
- metabolická clearance MeSH
- metabolická inaktivace fyziologie MeSH
- oxidoreduktasy MeSH
- potkani Wistar MeSH
- stárnutí metabolismus MeSH
- xenobiotika farmakokinetika MeSH
- zvířata MeSH
- Check Tag
- krysa rodu Rattus MeSH
- mužské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- antioxidancia MeSH
- léčivé přípravky MeSH
- oxidoreduktasy MeSH
- xenobiotika MeSH
Process of aging is accompanied by changes in the biotransformation of xenobiotics and impairment of normal cellular functions by free radicals. Therefore, this study was designed to determine age-related differences in the activities and/or expressions of selected drug-metabolizing and antioxidant enzymes in young and old rats. Specific activities of 8 drug-metabolizing enzymes and 4 antioxidant enzymes were assessed in hepatic subcellular fractions of 6-week-old and 21-month-old male Wistar rats. Protein expressions of carbonyl reductase 1 (CBR1) and glutathione S-transferase (GST) were determined using immunoblotting. Remarkable age-related decrease in specific activities of CYP2B, CYP3A, and UDP-glucuronosyl transferase was observed, whereas no changes in activities of CYP1A2, flavine monooxygenase, aldo-keto reductase 1C, and antioxidant enzymes with advancing age were found. On the other hand, specific activity of CBR1 and GST was 2.4 folds and 5.6 folds higher in the senescent rats compared with the young ones, respectively. Interindividual variability in CBR1 activity increased significantly with rising age. We suppose that elevated activities of GST and CBR1 may protect senescent rats against xenobiotic as well as eobiotic electrophiles and reactive carbonyls, but they may alter metabolism of drugs, which are CBR1 and especially GSTs substrates.
Zobrazit více v PubMed
Testa B, Krämer SD. The Biochemistry of Drug Metabolism: Conjugations, Consequences of Metabolism, Influencing Factors. 1st edition. Zürich, Switzerland: Willey-VCH; 2010.
Benedetti MS, Whomsley R, Canning M. Drug metabolism in the paediatric population and in the elderly. Drug Discovery Today. 2007;12(15-16):599–610. PubMed
Klotz U. Pharmacokinetics and drug metabolism in the elderly. Drug Metabolism Reviews. 2009;41(2):67–76. PubMed
Klinger W. Developmental pharmacology and toxicology: biotransformation of drugs and other xenobiotics during postnatal development. European Journal of Drug Metabolism and Pharmacokinetics. 2005;30(1-2):3–17. PubMed
Warrington JS, Greenblatt DJ, von Moltke LL. Age-related differences in CYP3A expression and activity in the rat liver, intestine, and kidney. Journal of Pharmacology and Experimental Therapeutics. 2004;309(2):720–729. PubMed
Yun KU, Oh SJ, Oh JM, et al. Age-related changes in hepatic expression and activity of cytochrome P450 in male rats. Archives of Toxicology. 2010;84(12):939–946. PubMed
Wauthier V, Verbeeck RK, Calderon PB. The effect of ageing on cytochrome P450 enzymes: consequences for drug biotransformation in the elderly. Current Medicinal Chemistry. 2007;14(7):745–757. PubMed
Southorn PA, Powis G. Free radicals in medicine. I. Chemical nature and biologic reactions. Mayo Clinic Proceedings. 1988;63(4):381–389. PubMed
Rizvi SI, Maurya PK. Alterations in antioxidant enzymes during aging in humans. Molecular Biotechnology. 2007;37(1):58–61. PubMed
Dröge W. Free radicals in the physiological control of cell function. Physiological Reviews. 2002;82(1):47–95. PubMed
Ceballos-Picot I, Trivier J-M, Nicole A, Sinet P-M, Thevenin M. Age-correlated modifications of copper-zinc superoxide dismutase and glutathione-related enzyme activities in human erythrocytes. Clinical Chemistry. 1992;38(1):66–70. PubMed
Behne D, Kyriakopoulos A. Mammalian selenium-containing proteins. Annual Review of Nutrition. 2001;21:453–473. PubMed
Inal ME, Kanbak G, Sunal E. Antioxidant enzyme activities and malondialdehyde levels related to aging. Clinica Chimica Acta. 2001;305(1-2):75–80. PubMed
Barja G. Rate of generation of oxidative stress-related damage and animal longevity. Free Radical Biology and Medicine. 2002;33(9):1167–1172. PubMed
Gil L, Siems W, Mazurek B, et al. Age-associated analysis of oxidative stress parameters in human plasma and erythrocytes. Free Radical Research. 2006;40(5):495–505. PubMed
Gillette JR. Techniques for studying drug metabolism in vitro. In: La Du BN, Mandel HG, Way E, editors. Fundamentals of Drug Metabolism and Drug Disposition. Baltimore, Md, USA: The Williams and Wilkins Company; 1971. pp. 400–418.
Smith PK, Krohn RI, Hermanson GT, et al. Measurement of protein using bicinchoninic acid. Analytical Biochemistry. 1985;150(1):76–85. PubMed
Weaver RJ, Thompson S, Smith G, et al. A comparative study of constitutive and induced alkoxyresorufin O-dealkylation and individual cytochrome P450 forms in cynomolgus monkey (Macaca fascicularis), human, mouse, rat and hamster liver microsomes. Biochemical Pharmacology. 1994;47(5):763–773. PubMed
Omura T, Sato R. The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. The Journal of Biological Chemistry. 1964;239:2370–2378. PubMed
Cashman JR, Hanzlik RP. Microsomal oxidation of thiobenzamide. A photometric assay for the flavin-containing monooxygenase. Biochemical and Biophysical Research Communications. 1981;98(1):147–153. PubMed
Maté L, Virkel G, Lifschitz A, Ballent M, Lanusse C. Hepatic and extra-hepatic metabolic pathways involved in flubendazole biotransformation in sheep. Biochemical Pharmacology. 2008;76(6):773–783. PubMed
Palackal NT, Lee SH, Harvey RG, Blair IA, Penning TM. Activation of polycyclic aromatic hydrocarbon trans-dihydrodiol proximate carcinogens by human aldo-keto reductase (AKR1C) enzymes and their functional overexpression in human lung carcinoma (A549) cells. Journal of Biological Chemistry. 2002;277(27):24799–24808. PubMed
Habig WH, Pabst MJ, Jakoby WB. Glutathione S transferases. The first enzymatic step in mercapturic acid formation. Journal of Biological Chemistry. 1974;249(22):7130–7139. PubMed
Mizuma T, Machida M, Hayashi M, Awazu S. Correlation of drug conjugative metabolism rates between in vivo and in vitro: glucuronidation and sulfation of p-nitrophenol as a model compound in rat. Journal of Pharmacobio-Dynamics. 1982;5(10):811–817. PubMed
Goth L. A simple method for determination of serum catalase activity and revision of reference range. Clinica Chimica Acta. 1991;196(2-3):143–151. PubMed
Flohé L, Günzler WA. Assays of glutathione peroxidase. Methods in Enzymology. 1984;105:114–121. PubMed
Handy DE, Lubos E, Yang Y, et al. Glutathione peroxidase-1 regulates mitochondrial function to modulate redox-dependent cellular responses. Journal of Biological Chemistry. 2009;284(18):11913–11921. PubMed PMC
Pérez FJ, Villegas D, Mejia N. Ascorbic acid and flavonoid-peroxidase reaction as a detoxifying system of H2O2 in grapevine leaves. Phytochemistry. 2002;60(6):573–580. PubMed
Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227(5259):680–685. PubMed
Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proceedings of the National Academy of Sciences of the United States of America. 1979;76(9):4350–4354. PubMed PMC
Farahmand SK, Samini F, Samini M, Samarghandian S. Safranal ameliorates antioxidant enzymes and suppresses lipid peroxidation and nitric oxide formation in aged male rat liver. Biogerontology. 2013;14(1):63–71. PubMed
Parkinson A. Biotransformation of Xenobiotics. In: Klaassen CD, editor. Casarett and Doull’s Toxicology: The Basic Science of Poisons. New York, NY, USA: McGraw-Hill; 2001. pp. 133–224.
Chengelis CP. Age- and sex-related changes in the components of the hepatic microsomal mixed function oxidase system in Sprague-Dawley rats. Xenobiotica. 1988;18(11):1211–1224. PubMed
Wauthier V, Verbeeck RK, Calderon PB. Age-related changes in the protein and mRNA levels of CYP2E1 and CYP3A isoforms as well as in their hepatic activities in Wistar rats. What role for oxidative stress? Archives of Toxicology. 2004;78(3):131–138. PubMed
Schmucker DL. Liver function and phase I drug metabolism in the elderly: a paradox. Drugs and Aging. 2001;18(11):837–851. PubMed
Handler JA, Brian WR. Effect of aging on mixed-function oxidation and conjugation by isolated perfused rat livers. Biochemical Pharmacology. 1997;54(1):159–164. PubMed
Burke MD, Thompson S, Weaver RJ, Wolf CR, Mayer RT. Cytochrome P450 specificities of alkoxyresorufin O-dealkylation in human and rat liver. Biochemical Pharmacology. 1994;48(5):923–936. PubMed
Kobayashi K, Urashima K, Shimada N, Chiba K. Substrate specificity for rat cytochrome P450 (CYP) isoforms: screening with cDNA-expressed systems of the rat. Biochemical Pharmacology. 2002;63(5):889–896. PubMed
Hines RN, Cashman JR, Philpot RM, Williams DE, Ziegler DM. The mammalian flavin-containing monooxygenases: molecular characterization and regulation of expression. Toxicology and Applied Pharmacology. 1994;125(1):1–6. PubMed
Janmohamed A, Hernandez D, Phillips IR, Shephard EA. Cell-, tissue-, sex- and developmental stage-specific expression of mouse flavin-containing monooxygenases (Fmos) Biochemical Pharmacology. 2004;68(1):73–83. PubMed
Zhang J, Cashman JR. Quantitative analysis of FMO gene mRNA levels in human tissues. Drug Metabolism and Disposition. 2006;34(1):19–26. PubMed
Okamoto M, Kita T, Okuda H, Tanaka T, Nakashima T. Effects of aging on acute toxicity of nicotine in rats. Pharmacology and Toxicology. 1994;75(1):1–6. PubMed
Inazu N, Fujii T. Effects of age and calcium ion on testis carbonyl reductase in rats. Japanese Journal of Pharmacology. 1993;63(1):65–71. PubMed
Tarloff JB, Goldstein RS, Sozio RS, Hook JB. Hepatic and renal conjugation (phase II) enzyme activities in young adult, middle-aged, and senescent male Sprague-Dawley rats. Proceedings of the Society for Experimental Biology and Medicine. 1991;197(3):297–303. PubMed
Boušová I, Skálová L. Inhibition and induction of glutathione S-transferases by flavonoids: possible pharmacological and toxicological consequences. Drug Metabolism Reviews. 2012;44(4):267–286. PubMed
Helmy MM. Potential hepato-protective effect of a-tocopherol or simvastatin in aged rats. Pharmacological Reports. 2012;64(3):698–705. PubMed
Chengelis CP. Age- and sex-related changes in epoxide hydrolase, UDP-glucuronosyl transferase, glutathione S-transferase, and PAPS sulphotransferase in Sprague-Dawley rats. Xenobiotica. 1988;18(11):1225–1237. PubMed
Aydin AF, Küçükgergin C, Özdemirler-Erata G, Koçak-Toker N, Uysal M. The effect of carnosine treatment on prooxidant-antioxidant balance in liver, heart and brain tissues of male aged rats. Biogerontology. 2010;11(1):103–109. PubMed
Carrillo M-C, Nokubo M, Kitani K, Satoh K, Sato K. Age-related alterations of enzyme activities and subunits of hepatic glutathione S-transferases in male and female Fischer-344 rats. Biochimica et Biophysica Acta. 1991;1077(3):325–331. PubMed
Kim H-G, Hong S-M, Kim S-J, et al. Age-related changes in the activity of antioxidant and redox enzymes in rats. Molecules and Cells. 2003;16(3):278–284. PubMed
Oztürk O, Gümüşlü S. Changes in glucose-6-phosphate dehydrogenase, copper, zinc-superoxide dismutase and catalase activities, glutathione and its metabolizing enzymes, and lipid peroxidation in rat erythrocytes with age. Experimental Gerontology. 2004;39(2):211–216. PubMed
Maurya PK, Rizvi SI. Age-dependent changes in glutathione-S-transferase: correlation with total plasma antioxidant potential and red cell intracellular glutathione. Indian Journal of Clinical Biochemistry. 2010;25(4):398–400. PubMed PMC
Kassner N, Huse K, Martin H-J, et al. Carbonyl reductase 1 is a predominant doxorubicin reductase in the human liver. Drug Metabolism and Disposition. 2008;36(10):2113–2120. PubMed
Klaunig JE, Kamendulis LM, Hocevar BA. Oxidative stress and oxidative damage in carcinogenesis. Toxicologic Pathology. 2010;38(1):96–109. PubMed
Ji LL, Dillon D, Wu E. Alteration of antioxidant enzymes with aging in rat skeletal muscle and liver. The American Journal of Physiology. 1990;258(4):R918–R923. PubMed
Mármol F, Sánchez J, López D, et al. Role of oxidative stress and adenosine nucleotides in the liver of aging rats. Physiological Research. 2010;59(4):553–560. PubMed